Cargando…
Dipeptidyl Peptidase-4 Inhibitors and Diabetic Kidney Disease: A Narrative Review
Diabetic kidney disease is one of the most frequent complications in patients with diabetes mellitus and affects morbidity and mortality. The recent therapies include oral hypoglycemic drugs that, in addition to optimizing glycemic control and reducing the risk of hypoglycemia, may affect the develo...
Autores principales: | Daza-Arnedo, Rodrigo, Rico-Fontalvo, Jorge-Eduardo, Pájaro-Galvis, Nehomar, Leal-Martínez, Víctor, Abuabara-Franco, Emilio, Raad-Sarabia, María, Montejo-Hernández, Juan, Cardona-Blanco, María, Cabrales-Juan, José, Uparella-Gulfo, Isabella, Montiel, Luis Salgado |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664739/ https://www.ncbi.nlm.nih.gov/pubmed/34939016 http://dx.doi.org/10.1016/j.xkme.2021.07.007 |
Ejemplares similares
-
Molecular Mechanisms of Diabetic Kidney Disease
por: Rico-Fontalvo, Jorge, et al.
Publicado: (2022) -
Letter Regarding “Moderating Effects in Randomized Trials—Interpreting the P Value, Confidence Intervals, and Hazard Ratios”
por: Rico-Fontalvo, Jorge, et al.
Publicado: (2022) -
Insulin and the kidneys: a contemporary view on the molecular basis
por: Daza-Arnedo, Rodrigo, et al.
Publicado: (2023) -
Prevalence of Chronic Infection by Hepatitis C Virus in Asymptomatic Population With Risk Factors in Cartagena, Colombia
por: Imbeth-Acosta, Pedro, et al.
Publicado: (2022) -
Letter Regarding “Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations”
por: Rico-Fontalvo, Jorge, et al.
Publicado: (2022)